Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.
作者信息
Fadare Oluwole, Zheng Wenxin
出版信息
Am J Cancer Res. 2012;2(3):335-9. Epub 2012 Apr 21.
Abstract
摘要
相似文献
1
Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.子宫内膜浆液性癌（子宫乳头状浆液性癌）：癌前病变及预防性方法的理论前景
Am J Cancer Res. 2012;2(3):335-9. Epub 2012 Apr 21.
2
Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.子宫内膜腺体发育异常：一种新定义的子宫浆液性乳头状癌前驱病变。第一部分：形态学特征。
Int J Surg Pathol. 2004 Jul;12(3):207-23. doi: 10.1177/106689690401200302.
3
Pure compared with mixed serous endometrial carcinoma: two different entities?与混合浆液性子宫内膜癌相比，单纯性浆液性子宫内膜癌：两种不同的实体吗？
Obstet Gynecol. 2012 Dec;120(6):1371-81. doi: 10.1097/aog.0b013e318273732e.
4
Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.子宫内膜腺体发育异常：子宫浆液性乳头状癌的一种假定前驱病变。第二部分：分子特征。
Int J Surg Pathol. 2004 Oct;12(4):319-31. doi: 10.1177/106689690401200405.
5
Cutaneous metastasis of uterine papillary serous carcinoma.子宫浆液性乳头状癌的皮肤转移
Am J Dermatopathol. 2005 Oct;27(5):436-8. doi: 10.1097/01.dad.0000178002.19337.b1.
6
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.激肽释放酶10（hK10）在子宫浆液性乳头状癌中的过表达。
Am J Obstet Gynecol. 2006 May;194(5):1296-302. doi: 10.1016/j.ajog.2005.10.794. Epub 2006 Apr 21.
7
Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.子宫内膜腺体发育异常先于子宫浆液性乳头状癌出现。
Int J Gynecol Pathol. 2007 Jan;26(1):38-52. doi: 10.1097/01.pgp.0000228138.56222.4e.
8
Clinical aspects of uterine papillary serous carcinoma.子宫浆液性乳头状癌的临床特征
Curr Opin Obstet Gynecol. 2008 Feb;20(1):26-33. doi: 10.1097/GCO.0b013e3282f2b10d.
9
Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.子宫浆液性乳头状癌与子宫内膜样乳头状癌的免疫组织化学比较：发病机制线索
Int J Gynecol Pathol. 1999 Jul;18(3):233-7. doi: 10.1097/00004347-199907000-00008.
10
MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.MDM2和p53蛋白在子宫内膜癌组织学亚型中的表达
Mod Pathol. 1996 Dec;9(12):1165-9.
引用本文的文献
1
Malignant Pleural Effusion Due to Uterine Serous Carcinoma: An Unusual Presentation.子宫浆液性癌所致恶性胸腔积液：一种不寻常的表现。
Cureus. 2023 Jan 29;15(1):e34354. doi: 10.7759/cureus.34354. eCollection 2023 Jan.
2
Histopathologic diagnosis of endometrial precancers: Updates and future directions.子宫内膜癌前病变的组织病理学诊断：更新与未来方向。
Semin Diagn Pathol. 2022 May;39(3):137-147. doi: 10.1053/j.semdp.2021.12.001. Epub 2021 Dec 10.
3
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.泛素羧基末端水解酶L1（UCHL1）促进子宫浆液性癌细胞增殖和细胞周期进程。
Cancers (Basel). 2020 Jan 2;12(1):118. doi: 10.3390/cancers12010118.
4
Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.子宫内膜上皮内癌患者盆腔浆液性癌的主要来源。
Mod Pathol. 2015 Jan;28(1):118-27. doi: 10.1038/modpathol.2014.76. Epub 2014 Jun 13.
5
The emerging genomic landscape of endometrial cancer.子宫内膜癌的新兴基因组图谱。
Clin Chem. 2014 Jan;60(1):98-110. doi: 10.1373/clinchem.2013.205740. Epub 2013 Oct 29.
本文引用的文献
1
HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.HMGA2 在子宫浆液性癌中普遍表达，是诊断的有用辅助手段。
Histopathology. 2012 Mar;60(4):547-53. doi: 10.1111/j.1365-2559.2011.04105.x. Epub 2012 Jan 17.
2
Cancer statistics, 2012.癌症统计数据，2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
3
Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.Ⅰ期子宫乳头状浆液性癌患者的预后决定因素：一项 15 年多机构回顾性研究。
Int J Gynecol Cancer. 2012 Mar;22(3):417-24. doi: 10.1097/IGC.0b013e31823c6e36.
4
Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.I 期非浸润性和微浸润性子宫浆液性癌：与改善生存相关的全面分期。
Int J Gynecol Cancer. 2012 Feb;22(2):273-9. doi: 10.1097/IGC.0b013e318238df4d.
5
Management of women with surgically staged 1 uterine papillary serous cancer.手术分期为1期的子宫浆液性乳头状癌女性的管理
ISRN Obstet Gynecol. 2011;2011:146264. doi: 10.5402/2011/146264. Epub 2011 Sep 11.
6
Nrf2 expression in endometrial serous carcinomas and its precancers.子宫内膜浆液性癌及其癌前病变中Nrf2的表达
Int J Clin Exp Pathol. 2010 Dec 24;4(1):85-96.
7
A proposed model for endometrial serous carcinogenesis.子宫内膜浆液性癌发生的一种假说模型。
Am J Surg Pathol. 2011 Jan;35(1):e1-e14. doi: 10.1097/PAS.0b013e318202772e.
8
Minimal uterine serous carcinoma with extrauterine tumor of identical morphology: an immunohistochemical study of 13 cases.伴有形态相同的子宫外肿瘤的微小子宫浆液性癌：13例免疫组织化学研究
Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):75-9. doi: 10.1097/PAI.0b013e3181b1d10e.
9
Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.子宫乳头状浆液性癌：流行病学、发病机制与管理。
Curr Opin Obstet Gynecol. 2010 Feb;22(1):21-9. doi: 10.1097/GCO.0b013e328334d8a3.
10
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).早期子宫浆液性乳头状癌（UPSC）的最新临床病理研究
Gynecol Oncol. 2009 Nov;115(2):244-8. doi: 10.1016/j.ygyno.2009.07.030. Epub 2009 Aug 26.
Zotero 插件